ORAMED PHARMACEUTICALS INC.
ORMP
12 insider filings · Latest: Mar 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 1 4:03 PM | Hexter Joshua | Proposed Sale | 137,000 | $4.81 | $659.0K | — | View → |
| Jul 1, 2026 | Jul 1 3:47 PM | Gabay Avraham | Proposed Sale | 93,360 | $4.81 | $449.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Jan 29 9:05 PM | Joshua HexterCOO & CBO | Option Exercise | 19,000 | — | 0(D) | View → |
| Jan 22, 2026 | Jan 29 9:05 PM | Kidron MiriamDirector, Chief Scientific Officer | Option Exercise | 19,000 | — | 0(D) | View → |
| Jan 22, 2026 | Jan 29 9:05 PM | Avraham GabayChief Financial Officer | Option Exercise | 19,000 | — | 0(D) | View → |
| Jan 22, 2026 | Jan 29 9:05 PM | KIDRON NADAVDirector, President and CEO | Option Exercise | 109,000 | — | 0(D) | View → |